Samira Farboodmanesh

Samira Farboodmanesh, Ph.D., currently serves as Sr. Director of Regulatory Affairs at Hemab Therapeutics and previously held the same title at Lyra Therapeutics. With significant experience in regulatory affairs, Samira worked as Director of Global Regulatory Affairs in Rare Genetics and Hematology at Takeda, where additional responsibilities included serving as the Combination Product and Pharmaceutical Science Development Lead. Prior roles include Principal Device Engineering at AstraZeneca and Senior Development Engineer at EMD Millipore, contributing to a robust background in regulatory and engineering aspects of the pharmaceutical industry.